目次

Table of Contents

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market by Geography
Exhibit 05: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibit 06: Executive Summary - Chart on Market Segmentation by Therapy
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size
4.1 Global castration-resistant prostate cancer (CRPC) treatment market 2018 - 2022
Exhibit 18: Historic Market Size - Data Table on global castration-resistant prostate cancer (crpc) treatment market 2018 - 2022 ($ billion)
4.2 Distribution Channel Segment Analysis 2018 - 2022
Exhibit 19: Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ billion)
4.3 Therapy Segment Analysis 2018 - 2022
Exhibit 20: Historic Market Size - Therapy Segment 2018 - 2022 ($ billion)
4.4 Geography Segment Analysis 2018 - 2022
Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
4.5 Country Segment Analysis 2018 - 2022
Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)

5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Distribution Channel
6.1 Market segments
Exhibit 30: Chart on Distribution Channel - Market share 2023-2028 (%)
Exhibit 31: Data Table on Distribution Channel - Market share 2023-2028 (%)
6.2 Comparison by Distribution Channel
Exhibit 32: Chart on Comparison by Distribution Channel
Exhibit 33: Data Table on Comparison by Distribution Channel
6.3 Hospital pharmacies - Market size and forecast 2023-2028
Exhibit 34: Chart on Hospital pharmacies - Market size and forecast 2023-2028 ($ billion)
Exhibit 35: Data Table on Hospital pharmacies - Market size and forecast 2023-2028 ($ billion)
Exhibit 36: Chart on Hospital pharmacies - Year-over-year growth 2023-2028 (%)
Exhibit 37: Data Table on Hospital pharmacies - Year-over-year growth 2023-2028 (%)
6.4 Retail pharmacies - Market size and forecast 2023-2028
Exhibit 38: Chart on Retail pharmacies - Market size and forecast 2023-2028 ($ billion)
Exhibit 39: Data Table on Retail pharmacies - Market size and forecast 2023-2028 ($ billion)
Exhibit 40: Chart on Retail pharmacies - Year-over-year growth 2023-2028 (%)
Exhibit 41: Data Table on Retail pharmacies - Year-over-year growth 2023-2028 (%)
6.5 Online pharmacies - Market size and forecast 2023-2028
Exhibit 42: Chart on Online pharmacies - Market size and forecast 2023-2028 ($ billion)
Exhibit 43: Data Table on Online pharmacies - Market size and forecast 2023-2028 ($ billion)
Exhibit 44: Chart on Online pharmacies - Year-over-year growth 2023-2028 (%)
Exhibit 45: Data Table on Online pharmacies - Year-over-year growth 2023-2028 (%)
6.6 Market opportunity by Distribution Channel
Exhibit 46: Market opportunity by Distribution Channel ($ billion)
Exhibit 47: Data Table on Market opportunity by Distribution Channel ($ billion)

7 Market Segmentation by Therapy
7.1 Market segments
Exhibit 48: Chart on Therapy - Market share 2023-2028 (%)
Exhibit 49: Data Table on Therapy - Market share 2023-2028 (%)
7.2 Comparison by Therapy
Exhibit 50: Chart on Comparison by Therapy
Exhibit 51: Data Table on Comparison by Therapy
7.3 Hormonal therapy - Market size and forecast 2023-2028
Exhibit 52: Chart on Hormonal therapy - Market size and forecast 2023-2028 ($ billion)
Exhibit 53: Data Table on Hormonal therapy - Market size and forecast 2023-2028 ($ billion)
Exhibit 54: Chart on Hormonal therapy - Year-over-year growth 2023-2028 (%)
Exhibit 55: Data Table on Hormonal therapy - Year-over-year growth 2023-2028 (%)
7.4 Chemotherapy - Market size and forecast 2023-2028
Exhibit 56: Chart on Chemotherapy - Market size and forecast 2023-2028 ($ billion)
Exhibit 57: Data Table on Chemotherapy - Market size and forecast 2023-2028 ($ billion)
Exhibit 58: Chart on Chemotherapy - Year-over-year growth 2023-2028 (%)
Exhibit 59: Data Table on Chemotherapy - Year-over-year growth 2023-2028 (%)
7.5 Others - Market size and forecast 2023-2028
Exhibit 60: Chart on Others - Market size and forecast 2023-2028 ($ billion)
Exhibit 61: Data Table on Others - Market size and forecast 2023-2028 ($ billion)
Exhibit 62: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibit 63: Data Table on Others - Year-over-year growth 2023-2028 (%)
7.6 Market opportunity by Therapy
Exhibit 64: Market opportunity by Therapy ($ billion)
Exhibit 65: Data Table on Market opportunity by Therapy ($ billion)

8 Customer Landscape
8.1 Customer landscape overview
Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 67: Chart on Market share by geography 2023-2028 (%)
Exhibit 68: Data Table on Market share by geography 2023-2028 (%)
9.2 Geographic comparison
Exhibit 69: Chart on Geographic comparison
Exhibit 70: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
Exhibit 71: Chart on North America - Market size and forecast 2023-2028 ($ billion)
Exhibit 72: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
Exhibit 73: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibit 74: Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
Exhibit 75: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibit 76: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibit 77: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibit 78: Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
Exhibit 79: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibit 80: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibit 81: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibit 82: Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
Exhibit 83: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibit 84: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibit 85: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibit 86: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
Exhibit 87: Chart on US - Market size and forecast 2023-2028 ($ billion)
Exhibit 88: Data Table on US - Market size and forecast 2023-2028 ($ billion)
Exhibit 89: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibit 90: Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 China - Market size and forecast 2023-2028
Exhibit 91: Chart on China - Market size and forecast 2023-2028 ($ billion)
Exhibit 92: Data Table on China - Market size and forecast 2023-2028 ($ billion)
Exhibit 93: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibit 94: Data Table on China - Year-over-year growth 2023-2028 (%)
9.9 Canada - Market size and forecast 2023-2028
Exhibit 95: Chart on Canada - Market size and forecast 2023-2028 ($ billion)
Exhibit 96: Data Table on Canada - Market size and forecast 2023-2028 ($ billion)
Exhibit 97: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibit 98: Data Table on Canada - Year-over-year growth 2023-2028 (%)
9.10 Germany - Market size and forecast 2023-2028
Exhibit 99: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibit 100: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibit 101: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibit 102: Data Table on Germany - Year-over-year growth 2023-2028 (%)
9.11 UK - Market size and forecast 2023-2028
Exhibit 103: Chart on UK - Market size and forecast 2023-2028 ($ billion)
Exhibit 104: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
Exhibit 105: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibit 106: Data Table on UK - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity by geography
Exhibit 107: Market opportunity by geography ($ billion)
Exhibit 108: Data Tables on Market opportunity by geography ($ billion)

10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 109: Impact of drivers and challenges in 2023 and 2028
10.4 Market trends

11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 110: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 111: Overview on factors of disruption
11.4 Industry risks
Exhibit 112: Impact of key risks on business

12 Vendor Analysis
12.1 Vendors covered
Exhibit 113: Vendors covered
12.2 Market positioning of vendors
Exhibit 114: Matrix on vendor position and classification
12.3 Active Biotech AB
Exhibit 115: Active Biotech AB - Overview
Exhibit 116: Active Biotech AB - Product / Service
Exhibit 117: Active Biotech AB - Key offerings
12.4 Allarity Therapeutics Inc.
Exhibit 118: Allarity Therapeutics Inc. - Overview
Exhibit 119: Allarity Therapeutics Inc. - Product / Service
Exhibit 120: Allarity Therapeutics Inc. - Key offerings
12.5 Amgen Inc.
Exhibit 121: Amgen Inc. - Overview
Exhibit 122: Amgen Inc. - Product / Service
Exhibit 123: Amgen Inc. - Key offerings
12.6 Amneal Pharmaceuticals Inc.
Exhibit 124: Amneal Pharmaceuticals Inc. - Overview
Exhibit 125: Amneal Pharmaceuticals Inc. - Business segments
Exhibit 126: Amneal Pharmaceuticals Inc. - Key news
Exhibit 127: Amneal Pharmaceuticals Inc. - Key offerings
Exhibit 128: Amneal Pharmaceuticals Inc. - Segment focus
12.7 Astellas Pharma Inc.
Exhibit 129: Astellas Pharma Inc. - Overview
Exhibit 130: Astellas Pharma Inc. - Product / Service
Exhibit 131: Astellas Pharma Inc. - Key news
Exhibit 132: Astellas Pharma Inc. - Key offerings
12.8 Bayer AG
Exhibit 133: Bayer AG - Overview
Exhibit 134: Bayer AG - Business segments
Exhibit 135: Bayer AG - Key news
Exhibit 136: Bayer AG - Key offerings
Exhibit 137: Bayer AG - Segment focus
12.9 BeiGene Ltd.
Exhibit 138: BeiGene Ltd. - Overview
Exhibit 139: BeiGene Ltd. - Business segments
Exhibit 140: BeiGene Ltd. - Key offerings
Exhibit 141: BeiGene Ltd. - Segment focus
12.10 Dr Reddys Laboratories Ltd.
Exhibit 142: Dr Reddys Laboratories Ltd. - Overview
Exhibit 143: Dr Reddys Laboratories Ltd. - Business segments
Exhibit 144: Dr Reddys Laboratories Ltd. - Key offerings
Exhibit 145: Dr Reddys Laboratories Ltd. - Segment focus
12.11 F. Hoffmann La Roche Ltd.
Exhibit 146: F. Hoffmann La Roche Ltd. - Overview
Exhibit 147: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 148: F. Hoffmann La Roche Ltd. - Key news
Exhibit 149: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 150: F. Hoffmann La Roche Ltd. - Segment focus
12.12 Johnson and Johnson
Exhibit 151: Johnson and Johnson - Overview
Exhibit 152: Johnson and Johnson - Business segments
Exhibit 153: Johnson and Johnson - Key news
Exhibit 154: Johnson and Johnson - Key offerings
Exhibit 155: Johnson and Johnson - Segment focus
12.13 Merck KGaA
Exhibit 156: Merck KGaA - Overview
Exhibit 157: Merck KGaA - Business segments
Exhibit 158: Merck KGaA - Key news
Exhibit 159: Merck KGaA - Key offerings
Exhibit 160: Merck KGaA - Segment focus
12.14 Novartis AG
Exhibit 161: Novartis AG - Overview
Exhibit 162: Novartis AG - Business segments
Exhibit 163: Novartis AG - Key offerings
Exhibit 164: Novartis AG - Segment focus
12.15 Ono Pharmaceutical Co. Ltd.
Exhibit 165: Ono Pharmaceutical Co. Ltd. - Overview
Exhibit 166: Ono Pharmaceutical Co. Ltd. - Product / Service
Exhibit 167: Ono Pharmaceutical Co. Ltd. - Key offerings
12.16 Pfizer Inc.
Exhibit 168: Pfizer Inc. - Overview
Exhibit 169: Pfizer Inc. - Product / Service
Exhibit 170: Pfizer Inc. - Key news
Exhibit 171: Pfizer Inc. - Key offerings
12.17 Sanofi SA
Exhibit 172: Sanofi SA - Overview
Exhibit 173: Sanofi SA - Business segments
Exhibit 174: Sanofi SA - Key news
Exhibit 175: Sanofi SA - Key offerings
Exhibit 176: Sanofi SA - Segment focus

13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 177: Inclusions checklist
Exhibit 178: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 179: Currency conversion rates for US$
13.4 Research methodology
Exhibit 180: Research methodology
Exhibit 181: Validation techniques employed for market sizing
Exhibit 182: Information sources
13.5 List of abbreviations
Exhibit 183: List of abbreviations

Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market by Geography
Exhibits5: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibits6: Executive Summary - Chart on Market Segmentation by Therapy
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
Exhibits15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits18: Historic Market Size - Data Table on global castration-resistant prostate cancer (crpc) treatment market 2018 - 2022 ($ billion)
Exhibits19: Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ billion)
Exhibits20: Historic Market Size - Therapy Segment 2018 - 2022 ($ billion)
Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)
Exhibits23: Five forces analysis - Comparison between 2023 and 2028
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits29: Chart on Market condition - Five forces 2023 and 2028
Exhibits30: Chart on Distribution Channel - Market share 2023-2028 (%)
Exhibits31: Data Table on Distribution Channel - Market share 2023-2028 (%)
Exhibits32: Chart on Comparison by Distribution Channel
Exhibits33: Data Table on Comparison by Distribution Channel
Exhibits34: Chart on Hospital pharmacies - Market size and forecast 2023-2028 ($ billion)
Exhibits35: Data Table on Hospital pharmacies - Market size and forecast 2023-2028 ($ billion)
Exhibits36: Chart on Hospital pharmacies - Year-over-year growth 2023-2028 (%)
Exhibits37: Data Table on Hospital pharmacies - Year-over-year growth 2023-2028 (%)
Exhibits38: Chart on Retail pharmacies - Market size and forecast 2023-2028 ($ billion)
Exhibits39: Data Table on Retail pharmacies - Market size and forecast 2023-2028 ($ billion)
Exhibits40: Chart on Retail pharmacies - Year-over-year growth 2023-2028 (%)
Exhibits41: Data Table on Retail pharmacies - Year-over-year growth 2023-2028 (%)
Exhibits42: Chart on Online pharmacies - Market size and forecast 2023-2028 ($ billion)
Exhibits43: Data Table on Online pharmacies - Market size and forecast 2023-2028 ($ billion)
Exhibits44: Chart on Online pharmacies - Year-over-year growth 2023-2028 (%)
Exhibits45: Data Table on Online pharmacies - Year-over-year growth 2023-2028 (%)
Exhibits46: Market opportunity by Distribution Channel ($ billion)
Exhibits47: Data Table on Market opportunity by Distribution Channel ($ billion)
Exhibits48: Chart on Therapy - Market share 2023-2028 (%)
Exhibits49: Data Table on Therapy - Market share 2023-2028 (%)
Exhibits50: Chart on Comparison by Therapy
Exhibits51: Data Table on Comparison by Therapy
Exhibits52: Chart on Hormonal therapy - Market size and forecast 2023-2028 ($ billion)
Exhibits53: Data Table on Hormonal therapy - Market size and forecast 2023-2028 ($ billion)
Exhibits54: Chart on Hormonal therapy - Year-over-year growth 2023-2028 (%)
Exhibits55: Data Table on Hormonal therapy - Year-over-year growth 2023-2028 (%)
Exhibits56: Chart on Chemotherapy - Market size and forecast 2023-2028 ($ billion)
Exhibits57: Data Table on Chemotherapy - Market size and forecast 2023-2028 ($ billion)
Exhibits58: Chart on Chemotherapy - Year-over-year growth 2023-2028 (%)
Exhibits59: Data Table on Chemotherapy - Year-over-year growth 2023-2028 (%)
Exhibits60: Chart on Others - Market size and forecast 2023-2028 ($ billion)
Exhibits61: Data Table on Others - Market size and forecast 2023-2028 ($ billion)
Exhibits62: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibits63: Data Table on Others - Year-over-year growth 2023-2028 (%)
Exhibits64: Market opportunity by Therapy ($ billion)
Exhibits65: Data Table on Market opportunity by Therapy ($ billion)
Exhibits66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits67: Chart on Market share by geography 2023-2028 (%)
Exhibits68: Data Table on Market share by geography 2023-2028 (%)
Exhibits69: Chart on Geographic comparison
Exhibits70: Data Table on Geographic comparison
Exhibits71: Chart on North America - Market size and forecast 2023-2028 ($ billion)
Exhibits72: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
Exhibits73: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits74: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits75: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibits76: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibits77: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits78: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits79: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibits80: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibits81: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits82: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits83: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibits84: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibits85: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits86: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits87: Chart on US - Market size and forecast 2023-2028 ($ billion)
Exhibits88: Data Table on US - Market size and forecast 2023-2028 ($ billion)
Exhibits89: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits90: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits91: Chart on China - Market size and forecast 2023-2028 ($ billion)
Exhibits92: Data Table on China - Market size and forecast 2023-2028 ($ billion)
Exhibits93: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits94: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits95: Chart on Canada - Market size and forecast 2023-2028 ($ billion)
Exhibits96: Data Table on Canada - Market size and forecast 2023-2028 ($ billion)
Exhibits97: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibits98: Data Table on Canada - Year-over-year growth 2023-2028 (%)
Exhibits99: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibits100: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibits101: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits102: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits103: Chart on UK - Market size and forecast 2023-2028 ($ billion)
Exhibits104: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
Exhibits105: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits106: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits107: Market opportunity by geography ($ billion)
Exhibits108: Data Tables on Market opportunity by geography ($ billion)
Exhibits109: Impact of drivers and challenges in 2023 and 2028
Exhibits110: Overview on Criticality of inputs and Factors of differentiation
Exhibits111: Overview on factors of disruption
Exhibits112: Impact of key risks on business
Exhibits113: Vendors covered
Exhibits114: Matrix on vendor position and classification
Exhibits115: Active Biotech AB - Overview
Exhibits116: Active Biotech AB - Product / Service
Exhibits117: Active Biotech AB - Key offerings
Exhibits118: Allarity Therapeutics Inc. - Overview
Exhibits119: Allarity Therapeutics Inc. - Product / Service
Exhibits120: Allarity Therapeutics Inc. - Key offerings
Exhibits121: Amgen Inc. - Overview
Exhibits122: Amgen Inc. - Product / Service
Exhibits123: Amgen Inc. - Key offerings
Exhibits124: Amneal Pharmaceuticals Inc. - Overview
Exhibits125: Amneal Pharmaceuticals Inc. - Business segments
Exhibits126: Amneal Pharmaceuticals Inc. - Key news
Exhibits127: Amneal Pharmaceuticals Inc. - Key offerings
Exhibits128: Amneal Pharmaceuticals Inc. - Segment focus
Exhibits129: Astellas Pharma Inc. - Overview
Exhibits130: Astellas Pharma Inc. - Product / Service
Exhibits131: Astellas Pharma Inc. - Key news
Exhibits132: Astellas Pharma Inc. - Key offerings
Exhibits133: Bayer AG - Overview
Exhibits134: Bayer AG - Business segments
Exhibits135: Bayer AG - Key news
Exhibits136: Bayer AG - Key offerings
Exhibits137: Bayer AG - Segment focus
Exhibits138: BeiGene Ltd. - Overview
Exhibits139: BeiGene Ltd. - Business segments
Exhibits140: BeiGene Ltd. - Key offerings
Exhibits141: BeiGene Ltd. - Segment focus
Exhibits142: Dr Reddys Laboratories Ltd. - Overview
Exhibits143: Dr Reddys Laboratories Ltd. - Business segments
Exhibits144: Dr Reddys Laboratories Ltd. - Key offerings
Exhibits145: Dr Reddys Laboratories Ltd. - Segment focus
Exhibits146: F. Hoffmann La Roche Ltd. - Overview
Exhibits147: F. Hoffmann La Roche Ltd. - Business segments
Exhibits148: F. Hoffmann La Roche Ltd. - Key news
Exhibits149: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits150: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits151: Johnson and Johnson - Overview
Exhibits152: Johnson and Johnson - Business segments
Exhibits153: Johnson and Johnson - Key news
Exhibits154: Johnson and Johnson - Key offerings
Exhibits155: Johnson and Johnson - Segment focus
Exhibits156: Merck KGaA - Overview
Exhibits157: Merck KGaA - Business segments
Exhibits158: Merck KGaA - Key news
Exhibits159: Merck KGaA - Key offerings
Exhibits160: Merck KGaA - Segment focus
Exhibits161: Novartis AG - Overview
Exhibits162: Novartis AG - Business segments
Exhibits163: Novartis AG - Key offerings
Exhibits164: Novartis AG - Segment focus
Exhibits165: Ono Pharmaceutical Co. Ltd. - Overview
Exhibits166: Ono Pharmaceutical Co. Ltd. - Product / Service
Exhibits167: Ono Pharmaceutical Co. Ltd. - Key offerings
Exhibits168: Pfizer Inc. - Overview
Exhibits169: Pfizer Inc. - Product / Service
Exhibits170: Pfizer Inc. - Key news
Exhibits171: Pfizer Inc. - Key offerings
Exhibits172: Sanofi SA - Overview
Exhibits173: Sanofi SA - Business segments
Exhibits174: Sanofi SA - Key news
Exhibits175: Sanofi SA - Key offerings
Exhibits176: Sanofi SA - Segment focus
Exhibits177: Inclusions checklist
Exhibits178: Exclusions checklist
Exhibits179: Currency conversion rates for US$
Exhibits180: Research methodology
Exhibits181: Validation techniques employed for market sizing
Exhibits182: Information sources
Exhibits183: List of abbreviations